Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The VAR2CSA protein of Plasmodium falciparum is transported to and expressed on the infected erythrocyte surface where it plays a key role in placental malaria (PM). It is the current leading candidate for a vaccine to prevent PM. However, the antigenic polymorphism integral to VAR2CSA poses a challenge for vaccine development. Based on detailed analysis of polymorphisms in the sequence of its ligand-binding N-terminal region, currently the main focus for vaccine development, we assessed var2csa from parasite isolates infecting pregnant women. The results reveal for the first time the presence of a major dimorphic region in the functionally critical N-terminal ID1 domain. Parasite isolates expressing VAR2CSA with particular motifs present within this domain are associated with gravidity- and parasite density-related effects. These observations are of particular interest in guiding efforts with respect to optimization of the VAR2CSA-based vaccines currently under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, the VAR2CSA sequences lacking the PAM1.4-binding residues KR in ID1 cluster in a clade of variants that share a distinct type 2 dimorphic sequence motif (DSM) in ID1 and constitute about a quarter of known VAR2CSA sequences [3].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sequence polymorphism in VAR2CSA represents an important issue for variant selection in PM vaccine development, as many studies of var2csa genetic diversity have highlighted significant sequence variation across the gene [2,3,14].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Relatively high polymorphism in VAR2CSA sequences has hindered development of a vaccine that induces broadly neutralizing immunity.”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205 · cited 1×
“Tajima’s D test as implemented in MEGA 6 [43] and DnaSP [44], and pairwise nucleotide diversity (π) were used to analyze sequence diversity.”
MethodHall, T. A. (1999) · Nucleic Acids Symposium Series · doi:10.14601/phytopathol_mediterr-14998u1.29 · Cited by 38,297
DnaSP v5: a software for comprehensive analysis of DNA polymorphism data
Librado, P., & Rozas, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp187 · Cited by 16,017
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Self-citationValdar, W. S. J. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10146 · Cited by 635
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 1×
“VAR2CSA is currently considered as the prime candidate for vaccine development [19] because: (i) VAR2CSA-expressing parasites are the primary cause of PM, (ii) anti-VAR2CSA antibody levels increase with gravidity, as do the levels of antibodies that inhibit IE binding to CSA, (iii) women who have been exposed to PM an…”
BackgroundSelf-citationSnounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N., & Viriyakosol, S. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90120-7 · Cited by 546 · cited 1×
“Msp1 andmsp2 genes were amplified by nested PCR, as described [41].”
MethodSmith, J. D., Subramanian, G., Gamain, B., Baruch, D. I., & Miller, L. H. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00279-6 · Cited by 276 · cited 1×
“VAR2CSA is a large trans-membrane polymorphic protein (~350 kDa) consisting of six duffy-binding like (DBL) domains [23].”
BackgroundROGERSON, S. J., POLLINA, E., GETACHEW, A., TADESSE, E., LEMA, V. M., & MOLYNEUX, M. E. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.1.0680115 · Cited by 275
Duffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260
Kelly-Hope, L. A., & McKenzie, F. E. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-19 · Cited by 203
Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90082-3 · Cited by 197 · cited 3×
“Differences in the geographic origin of parasites used in this study and those analyzed in these previous studies conducted in East and South-Eastern Africa may account for the difference in the level of sequences polymorphism.”
BackgroundHigh Level of var2csa Transcription by Plasmodium falciparum Isolated from the Placenta
Tuikue Ndam, N. G., Salanti, A., Bertin, G., Dahlbäck, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005) · The Journal of Infectious Diseases · doi:10.1086/430933 · Cited by 179
Self-citationClausen, T. M., Christoffersen, S., Dahlbäck, M., Langkilde, A. E., Jensen, K. E., Resende, M., Agerbæk, M. Ø., Andersen, D., Berisha, B., Ditlev, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348839 · Cited by 173 · cited 3×
“First, the minimal binding region to placental CSA has been defined in this fragment [25].”
BackgroundSelf-citationChan, J.-A., Fowkes, F. J. I., & Beeson, J. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1614-3 · Cited by 168
Trimnell, A. R., Kraemer, S. M., Mukherjee, S., Phippard, D. J., Janes, J. H., Flamoe, E., Su, X.-Z., Awadalla, P., & Smith, J. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.012 · Cited by 165
O'Neil-Dunne, I., Achur, R. N., Agbor-Enoh, S. T., Valiyaveettil, M., Naik, R. S., Ockenhouse, C. F., Zhou, A., Megnekou, R., Leke, R., Taylor, D. W., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7487-7492.2001 · Cited by 156
Conroy, A. L., Silver, K., Zhong, K., Rennie, M. Y., Ward, P. A., Sarma, J. V., Molyneux, M. E., Sled, J. G., Fletcher, J. F., Rogerson, S. J., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.01.010 · Cited by 141 · cited 1×
“Several natural immune mechanisms including opsonic phagocytosis [9,10], complement activation [11,12] and agglutination [13,14] against placental isolates have been reported as components”
BackgroundBockhorst, J., Lu, F., Janes, J. H., Keebler, J., Gamain, B., Awadalla, P., Su, X.-Z., Samudrala, R., Jojic, N., & Smith, J. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.06.007 · Cited by 117 · cited 5×
“In this new clustering pattern, FCR3- and 3D7-like variants, as defined by the DBL2X DSM, are combined in the same large cluster, and a second cluster contains rarely described variants of P. falciparum such as WR80 (originating from South-East Asia) [31], not documented in Africa so far.”
BackgroundResultInfluentialProtective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
Self-citationMaubert, B., Fievet, N., Tami, G., Cot, M., Boudin, C., & Deloron, P. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5367-5371.1999 · Cited by 95 · cited 1×
“Several natural immune mechanisms including opsonic phagocytosis [9,10], complement activation [11,12] and agglutination [13,14] against placental isolates have been reported as components”
BackgroundSelf-citationHIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
Keen, J., Serghides, L., Ayi, K., Patel, S. N., Ayisi, J., van Eijk, A., Steketee, R., Udhayakumar, V., & Kain, K. C. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040181 · Cited by 92
Nielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92
Self-citationUmbers, A. J., Boeuf, P., Clapham, C., Stanisic, D. I., Baiwog, F., Mueller, I., Siba, P., King, C. L., Beeson, J. G., Glazier, J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq080 · Cited by 90
Dynamics of Anti‐VAR2CSA Immunoglobulin G Response in a Cohort of Senegalese Pregnant Women
Tuikue Ndam, N. G., Salanti, A., Le‐Hesran, J. ‐., Cottrell, G., Fievet, N., Turner, L., Sow, S., Dangou, J. ‐., Theander, T., & Deloron, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500146 · Cited by 89
Self-citationStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79
Self-citationRisk factors for fetal anaemia in a malarious area of Malawi
Brabin, B. J., Kalanda, B. F., Verhoeff, F. H., Chimsuku, L. H., & Broadhead, R. L. (2004) · Annals of Tropical Paediatrics · doi:10.1179/027249304225019136 · Cited by 67
Sander, A. F., Salanti, A., Lavstsen, T., Nielsen, M. A., Magistrado, P., Lusingu, J., Ndam, N. T., & Arnot, D. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006667 · Cited by 64 · cited 4×
“The DSM described in the DBL2X domain of VAR2CSA [27] was also present in this independent set of sequences.”
BackgroundSelf-citationBigey, P., Gnidehou, S., Doritchamou, J., Quiviger, M., Viwami, F., Couturier, A., Salanti, A., Nielsen, M. A., Scherman, D., Deloron, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir499 · Cited by 63 · cited 5×
“Recent studies have identified the minimal determining portion of the N-terminal region of VAR2CSA that retains the major amino acids residues targeted by anti-adhesion antibodies as well as the interaction site with CSA [21,24,25].”
BackgroundMethodSelf-citationMolecular mechanisms of Plasmodium falciparum placental adhesion . Microreview
Scherf, A., Pouvelle, B., Buffet, P. A., & Gysin, J. (2001) · Cellular Microbiology · doi:10.1046/j.1462-5822.2001.00109.x · Cited by 61 · cited 1×
“Expression of VAR2CSA on the IE surface is the key factor for IE accumulation in the placenta [8].”
BackgroundBeeson, J. G., Mann, E. J., Byrne, T. J., Caragounis, A., Elliott, S. R., Brown, G. V., & Rogerson, S. J. (2006) · The Journal of Infectious Diseases · doi:10.1086/500145 · Cited by 60
Hommel, M., Elliott, S. R., Soma, V., Kelly, G., Fowkes, F. J. I., Chesson, J. M., Duffy, M. F., Bockhorst, J., Avril, M., Mueller, I., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01365-09 · Cited by 57
Zhou, J., Ludlow, L. E. A., Hasang, W., Rogerson, S. J., & Jaworowski, A. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-343 · Cited by 54
First-Trimester Plasmodium falciparum Infections Display a Typical “Placental” Phenotype
Doritchamou, J., Bertin, G., Moussiliou, A., Bigey, P., Viwami, F., Ezinmegnon, S., Fievet, N., Massougbodji, A., Deloron, P., & Tuikue Ndam, N. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis629 · Cited by 52 · cited 1×
“RNAs were treated with DNase I (Invitrogen) to remove possible contamination of gDNA, as described [42].”
MethodSelf-citationBordbar, B., Ndam, N. T., Bigey, P., Doritchamou, J., Scherman, D., & Deloron, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.065 · Cited by 43
Self-citationAvril, M., Hathaway, M. J., Srivastava, A., Dechavanne, S., Hommel, M., Beeson, J. G., Smith, J. D., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016622 · Cited by 40
Wort, U. U., Hastings, I. M., Mutabingwa, T., & Brabin, B. J. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-89 · Cited by 35
The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria
Hviid, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.113 · Cited by 34
Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains?
Dahlbäck, M., Nielsen, M. A., & Salanti, A. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.02.002 · Cited by 32
Self-citationSPEER-SERVER: a web server for prediction of protein specificity determining sites
Chakraborty, A., Mandloi, S., Lanczycki, C. J., Panchenko, A. R., & Chakrabarti, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks559 · Cited by 32
Doritchamou, J., Bigey, P., Nielsen, M. A., Gnidehou, S., Ezinmegnon, S., Burgain, A., Massougbodji, A., Deloron, P., Salanti, A., & Ndam, N. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.072 · Cited by 29 · cited 3×
“Second, antibodies to antigenic constructs from this region of VAR2CSA show greater inhibitory property than antibodies to other regions [21,24,28].”
BackgroundMethodSelf-citationBordbar, B., Ndam, N. T., Renard, E., Jafari‐Guemouri, S., Tavul, L., Jennison, C., Gnidehou, S., Tahar, R., Gamboa, D., Bendezú, J., et al. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.04.010 · Cited by 26
Self-citationPfEMP1 as a target of human immunity and a vaccine candidate against malaria
Beeson, J. G., Chan, J.-A., & Fowkes, F. J. I. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.144 · Cited by 25 · cited 1×
“A multivalent VAR2CSA vaccine candidate able to induce a broad antibody repertoire against the most common and biologically relevant variants may overcome antigenic diversity [36,38].”
BackgroundJessen, L. E., Hoof, I., Lund, O., & Nielsen, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt497 · Cited by 20 · cited 1×
“1 server [48] was used for quantitative phenotypes (GA [weeks], peripheral blood parasite density [parasites/μL of blood], and CSPG-binding density [parasites/mm(2)]).”
MethodSelf-citationPlasmodium falciparum population dynamics in a cohort of pregnant women in Senegal
Guitard, J., Andersen, P., Ermont, C., Gnidehou, S., Fiévet, N., Lund, O., Deloron, P., & Ndam, N. T. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-165 · Cited by 19
Self-citationDoritchamou, J., Sossou-tchatcha, S., Cottrell, G., Moussiliou, A., Hounton Houngbeme, C., Massougbodji, A., Deloron, P., & Ndam, N. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098577 · Cited by 16 · cited 2×
“The binding level of IE to CSPG was assessed on a static assay, as described [39].”
MethodSelf-citationVAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta
Rovira-Vallbona, E., Monteiro, I. F., Bardají, A., Serra‐Casas, E., Neafsey, D. E., Quelhas, D., Valim, C., Alonso, P. L., Dobaño, C., Ordï, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069753 · Cited by 16 · cited 1×
“The pairwise nucleotide diversity of NTS-ID2a and subunits is higher than that of DBL2 and DBL3 domains of VAR2CSA [33,34].”
BackgroundTalundzic, E., Shah, S., Fawole, O., Owino, S. O., Moore, J. M., & Peterson, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031565 · Cited by 14 · cited 1×
“The pairwise nucleotide diversity of NTS-ID2a and subunits is higher than that of DBL2 and DBL3 domains of VAR2CSA [33,34].”
Background
Research works printed but not linked: 1
- Nicaise T. Ndam, 2015, Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin, Emerging Infectious Disease journal, 21
Cited by
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem
Rogerson, S. J., Desai, M., Mayor, A., Sicuri, E., Taylor, S. M., & van Eijk, A. M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30066-5 · Cited by 306
Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154
Self-citationPatel, J. C., Hathaway, N. J., Parobek, C. M., Thwai, K. L., Madanitsa, M., Khairallah, C., Kalilani‐Phiri, L., Mwapasa, V., Massougbodji, A., Fiévet, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04737-y · Cited by 37
Self-citationTomlinson, A., Semblat, J., Gamain, B., & Chêne, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624126 · Cited by 39
Molecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection
Seitz, J., Prieto, D. M. M., Fávaro, R. R., Schneider, H., & Markert, U. R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00098 · Cited by 36
“(cluster 2) (192) Does not bind to CSA 3D7 (191)”
BackgroundInfluential
Metadata
- Authors
- Doritchamou, J., Sabbagh, A., Jespersen, J. S., Renard, E., Salanti, A., Nielsen, M. A., Deloron, P., & Tuikue Ndam, N.
- Affiliations
- Sorbonne Paris Cité (FR)
- University of Copenhagen (DK)
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-22
- Volume
- 10
- Issue
- 9
- Pages
- e0137695
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4579133
- OpenAlex
- W2211906639
- Cited by
- 22
- References
- 48
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 1
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Université Paris Descartes
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- VAR2CSA, Plasmodium falciparum, placental malaria, antigenic polymorphism, vaccine development, gravidity, parasite density, ligand-binding domain, pregnant women
- MeSH terms
- Antigens, Protozoan, Erythrocytes, Female, Gestational Age, Humans, Molecular Sequence Data, Phylogeny, Plasmodium falciparum, Pregnancy, Vaccines, Synthetic, Genetic Variation, Protein Structure, Tertiary, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.